OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5925.19M
Enterprise Value 31.25B
Trailing P/E N/A
Forward P/E 1-4.63
PEG Ratio (5 yr expected) 1-0.31
Price/Sales (ttm)1.03
Price/Book (mrq)0.52
Enterprise Value/Revenue 31.39
Enterprise Value/EBITDA 6-9.34

Trading Information

Stock Price History

Beta (5Y Monthly) 2.31
52-Week Change 3-46.04%
S&P500 52-Week Change 315.52%
52 Week High 32.8600
52 Week Low 31.3300
50-Day Moving Average 31.5512
200-Day Moving Average 31.7174

Share Statistics

Avg Vol (3 month) 33.96M
Avg Vol (10 day) 33.24M
Shares Outstanding 5665.6M
Float 407.35M
% Held by Insiders 139.64%
% Held by Institutions 126.96%
Shares Short (Jan 30, 2020) 483.31M
Short Ratio (Jan 30, 2020) 420.53
Short % of Float (Jan 30, 2020) 422.96%
Short % of Shares Outstanding (Jan 30, 2020) 412.52%
Shares Short (prior month Dec 30, 2019) 480.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -30.98%
Operating Margin (ttm)-25.43%

Management Effectiveness

Return on Assets (ttm)-5.89%
Return on Equity (ttm)-16.25%

Income Statement

Revenue (ttm)899.45M
Revenue Per Share (ttm)1.54
Quarterly Revenue Growth (yoy)-8.40%
Gross Profit (ttm)314.61M
EBITDA -133.57M
Net Income Avi to Common (ttm)-278.65M
Diluted EPS (ttm)-0.4780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.67M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)314.16M
Total Debt/Equity (mrq)19.13
Current Ratio (mrq)1.08
Book Value Per Share (mrq)2.67

Cash Flow Statement

Operating Cash Flow (ttm)-161.14M
Levered Free Cash Flow (ttm)-67.54M